US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist
  • 264.210
  • +2.150+0.82%
Close Jan 8 16:00 ET
  • 260.699
  • -3.511-1.33%
Post 20:01 ET
142.02BMarket Cap33.74P/E (TTM)

Amgen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amgen Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 8.165B--
--2024/Q4-- / 8.864B--
Oct 30, 20242024/Q38.503B / 8.499B--
Aug 6, 20242024/Q28.388B / 8.348B--
May 2, 20242024/Q17.447B / 7.453B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 8.165B--
--2024/Q4-- / 8.864B--
Oct 30, 20242024/Q38.503B / 8.499B--
Aug 6, 20242024/Q28.388B / 8.348B--
May 2, 20242024/Q17.447B / 7.453B--

Unlock Free Earnings Estimates

Amgen Earnings Reports

  • Amgen | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 14:46 ET

  • Amgen | 8-K: AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

    Oct 30, 2024 16:08 ET

  • Amgen | 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 16:05 ET

  • Amgen | 8-K: AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

    Aug 6, 2024 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 9, 2025

    Buy

    • Buy

      54.55%

    • Hold

      40.91%

    • Sell

      4.55%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Weight Loss Drugs
    Weight Loss Drugs
    Intraday+1.63%
    CAR-T Therapy
    CAR-T Therapy
    Intraday-0.95%